After Dow Chemical's announcement of its $18.8bn acquisition of Rohm and Haas and Ashland's plan to buy Hercules for $3.3bn, what might be coming next? Chemtura is keeping all its options on the table, including a sale. But private equity remains hampered by the global credit crisis.
Who could be sold, and what is the outlook for more chemical M&A?
Opinions wanted!
Joe